Study of the cell biology and biochemistry of cherubism

Journal of Clinical Pathology

Volumn 51, Issue 11, 1998, Pages 831-837

  Southgate, John ^b   Sarma, Usha ^c   Townend, John V ^a   Barron, Jeffrey ^b   Flanagan, Adrienne M ^c  

^a Department of Maxillofacial Surgery   (United Kingdom)

^b WORTHING HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bone resorption; Calcitonin; Cherubism; Osteoclast; Parathyroid hormone

Indexed keywords

ACID PHOSPHATASE; BIOCHEMICAL MARKER; CALCITONIN; CALCIUM ION; HYDROXYPROLINE; PARATHYROID HORMONE; PYRIDINIUM DERIVATIVE; VITRONECTIN RECEPTOR;

ADOLESCENT; ARTICLE; BONE TURNOVER; CHILD; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FIBROUS DYSPLASIA; HUMAN; HUMAN TISSUE; JAW MALFORMATION; MALE; MULTINUCLEAR CELL; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0031770934     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.11.831     Document Type: Article

References (38)

1. Peters WJN. Cherubism: a study of twenty cases from one family. Oral Surg Oral Med Oral Pathol 1979;47:307-11.
2. Jones WA. Familial multilocular cystic disease of the jaws. Am J Cancer 1933;17:946-50.
3. Topazian RG, Cotish ER. Familial fibrous dysplasia of the jaws (cherubism): report of a case. Oral Surg 1965;559-66.
4. Grunebaum M, Tiqva P. Non familial cherubism: report of two cases. J Oral Surg 1973;31:632-5.
5. Kaugars GE, Svirsky JA. Cherubism: diagnosis, treatment and comparison with central giant cell granulomas and giant cell tumour. Oral Surg Oral Med Oral Pathol 1992;73: 369-74.
6. Killey HC, Seward GR, Kay LW. An outline of oral surgery, part II. Bristol: Wright and sons, 1978:92-4.
7. Wayman JB. Cherubism: a report on three cases. Br J Oral Surg 1978;16:47-56.
8. Jones WA. Cherubism. Oral Surg Oral Med Oral Pathol 1965;20:648-53.
9. Pindborg JJ, Kramer IRH, Torlini H. Histological typing of odontogenic tumours, jaw cysts and allied lesions. Geneva: World Health Organisation, 1976.
10. Regezi JA, Sciubba JJ. Oral pathology: clinical-pathologic correlations. Philadelphia: WB Saunders, 1989;379-82, 437-9.
11. Jaffe HL. Giant cell reparative granuloma, traumatic bone cyst and fibrous (fibro-osseous) dysplasia of the jaw bones. Oral Surg Oral Med Oral Pathol 1953;6:159-75.
12. Riefkohl R, Georgiade GS, Georgiade NG. Cherubism. Ann Plastic Surg 1985;14:85-9.
13. Chambers TJ, Fuller K, McSheehy PMJ, et al. The effect of calcium-regulating hormones on bone resorption by isolated osteoclastoma cells. J Pathol 1985;145:297-305.
14. Flanagan AM, Tinkler SMB, Horton MA, et al. The multinucleate cells in giant cell granulomas of the jaw are osteoclasts. Cancer 1988;62:1139-45.
15. Harris M. Central giant cell granulomas of the jaws regress with calcitonin therapy. Br J Oral Maxillofac Surg 1993;31: 89-94.
16. Chambers TJ, Revell PA, Fuller K, et al. Resorption of bone by isolated rabbit osteoclasts. J Cell Sci 1984;66:383-99.
17. Horton MA, Lewis D, McNulty K, et al. Monoclonal antibodies to osteoclastomas (giant cell bone tumours): definition of osteoclast-specific cellular antigens. Cancer Res 1985;45:5663-9.
18. Davies J, Warwick J, Tutty N, et al. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 1989;109:1817-26.
19. Gosden CM, Davidson C, Robertson M. In: Rooney DE, Czepulkowski BH, eds. Human cytogenetics: a practical approach. New York: Oxford University Press, 1992:31-54.
20. Prokof DJ, Udenfriend S. A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem 1960; 1:228.
21. Ibrahim S, Mojiminiyi S, Barron J. High performance liquid chromatographic determination of pyridinium crosslinks in serum, urine and dialysate of patients in chronic renal failure. Ann Clin Biochem 1996;33:31-5.
22. Wharton BA, Gough G, Williams A, et al. Urinary total hydroxyproline:creatinine ratio. Range of normal, and clinical applications in British children. Arch Dis Child 1972;47:74-9.
23. Rauch F, Schonau E, Woitge H, et al. Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children. Exp Clin Endocrinol 1994;102:94-7.
24. Matos V, van Melle G, Boulat O, et al. Urinary phosphate/creatinine, calcium creatinine and magnesium creatinine ratios in a healthy pediatric population. J Pediatr 1997;131:252-7.
25. Sweid HA, Bagga A, Vaswani M, et al. Urinary excretions of minerals, oxalate and uric acid in north Indian children. Pediatr Nephrol 1997;11:189-92.
26. Chambers TJ, Magnus CJ. Calcitonin alters behaviour of isolated osteoclasts. J Pathol 1982;136:27-39.
27. Chambers TJ. The cellular basis of bone resorption. Clin Orthop Rel Res 1980;151:283-93.
28. Rodan GA, Martin TJ. The role of osteoblasts in hormonal control of bone resorption. Calcif Tiss Int 1981;33:349-51.
29. Flanagan AM, Chambers TJ. Osteoclasts are present in the giant cell variant of malignant fibrous histiocytoma. J Pathol 1989;159:53-7.
30. Sarma U, Edwards M, Motoyoshi K, et al. 17β-Estradiol inhibits human osteoclast formation in vitro. J Cell Physiol 1998;175:99-108.
31. Overgaard K, Riis BJ, Christiansen C, et al. Effect of calcitonin given intranasally on early postmenopausal bone loss. BMJ 1989;305:477-9.
32. Silva OL, Becker KL. Salmon calcitonin in the treatment of hypercalcaemia. Arch Intern Med 1973;132:337-9.
33. Wada S, Udagawa N, Nagata N, et al. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts. Endocrinology 1996;137:1042-8.
34. Davis JP, Archer DJ, Fisher C, et al. Multiple recurrent giant cell lesions associated with high circulating levels of parathyroid hormone-related peptide in a young adult. Br J Oral Maxillofac Surg 1991;29:102-5.
35. James IT, Walne AJ, Perrett D. The measurement of pyridinium crosslinks: a methodological overview. Ann Clin Biochem 1996;33:397-420.
36. Yoshida H, Hayashi S-I, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345: 442-4.
37. Grigoriadis AE, Wang Z-Q, Cecchini MG, et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994;266:443-7.
38. Soriano P, Montgomery C, Geske R, et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.